Companies which are potentially undervalued and in an acceptable financial position.

Analysts Target

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
NSL	฿22.70	-3.4%	-29.6%	฿6.8b	฿28.63	11.4	11.9%	4.6%	Food, Beverage & Tobacco
EMAAR	د.إ11.30	2.4%	-26.9%	د.إ99.9b	د.إ16.80	5.3	5.7%	8.8%	Real Estate Management and Development
HITI	CA$3.01	-1.6%	-3.2%	CA$268.0m	CA$7.30	0.4	65.6%	n/a	Pharmaceuticals & Biotech
BZ	US$15.73	0.9%	-20.7%	US$6.9b	US$20.75	14.1	6.4%	1.1%	Commercial Services
CADLR	NOK 53.95	-3.4%	-3.0%	NOK 20.8b	NOK 70.36	7.0	14.4%	n/a	Capital Goods
INF	€38.95	0.5%	3.9%	€266.4m	€51.55	16.5	13.4%	5.1%	Software
XP	US$16.74	-0.4%	3.2%	US$8.6b	US$23.54	8.4	11.5%	1.2%	Diversified Financials
74SW	€38.00	7.0%	-2.8%	€1.1b	€46.14	17.6	14.3%	0%	Software
ATMU	US$54.22	7.3%	40.0%	US$4.4b	US$66.40	21.0	11.1%	0.4%	Capital Goods
PLOW	US$44.81	-3.1%	55.1%	US$1.1b	US$55.25	19.9	15.0%	2.6%	Capital Goods
AR	US$33.85	1.9%	3.7%	US$10.9b	US$48.25	10.9	6.8%	n/a	Energy
FOUR	UK£40.36	2.4%	8.9%	UK£1.1b	UK£49.12	13.2	-5.3%	4.5%	Media
FLOC	US$19.11	-4.2%	-4.9%	US$1.8b	US$31.22	18.7	37.9%	1.9%	Energy
TESB	€20.55	-0.7%	-24.2%	€1.2b	€25.50	0.4	74.6%	3.6%	Materials
TRLV	US$8.33	-4.9%	67.6%	US$1.6b	US$18.71	1.4	131.9%	n/a	Pharmaceuticals & Biotech
EGLA	€0.96	-7.0%	-72.9%	€156.6m	€1.23	0.2	98.6%	4.4%	Capital Goods
TCL.A	CA$5.37	-5.1%	-72.8%	CA$455.9m	CA$7.17	2.9	-30.8%	3.7%	Materials
FRP	UK£1.15	5.5%	-9.4%	UK£279.2m	UK£2.05	10.7	7.9%	5.0%	Diversified Financials
VTURA	NOK 29.80	4.6%	42.6%	NOK 3.2b	NOK 42.42	3.3	9.1%	n/a	Energy
OSB	UK£5.62	1.1%	2.1%	UK£1.9b	UK£6.78	7.0	6.0%	6.3%	Diversified Financials
EN	€46.95	-2.3%	22.9%	€18.2b	€59.03	15.1	10.0%	4.5%	Capital Goods
LKNC.Y	US$31.53	-1.6%	-18.7%	US$10.5b	US$45.71	19.2	22.1%	n/a	Consumer Services
ICG	UK£19.38	4.5%	-9.9%	UK£5.3b	UK£24.83	11.2	11.0%	4.5%	Diversified Financials
CABKA	€1.91	-4.5%	-1.5%	€47.2m	€3.28	0.3	105.5%	0%	Materials

Healthy potentially undervalued